Starkage Therapeutics

About:

Starkage Therapeutics is a biotechnology company that aims to delay and improve quality of life of patients with age-related diseases.

Website: https://starkagetx.com/

Twitter/X: starkagetx

Top Investors: Bpifrance

Description:

Starkage Therapeutics is a discovery-stage biotechnology company. They also provide treatment for idiopathic pulmonary fibrosis, neurodegenerative diseases, and metabolic dysfunction or hepatic fibroses.

Total Funding Amount:

3.2M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lille, Nord-Pas-de-Calais, France

Founded Date:

2018-01-01

Contact Email:

contact(AT)starkagetx.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-05-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai